Varejao To Miss Remainder Of Season With Blood Clot In Lung
Anderson Varejao recently developed a blood clot (small right lower lung pulmonary embolism) and was admitted to the Cleveland Clinic last Thursday (January 17th). He is being treated with blood thinners (anticoagulants) and is expected to stay at the Clinic for several days, while undergoing treatment and observation.
He will need to remain on blood thinning medication for approximately three months.
While Varejao is expected to fully recover, he will miss the remainder of the current Cavaliers season.
"Clearly our players' health is our top concern and we are disappointed for Anderson, and his family," said general manager Chris Grant. "We know what a competitor he is and how much he wants to be on the court helping his teammates. In the meantime, he has our full support and we look forward to welcoming him back as he recovers."